Crinetics Pharmaceuticals
CRNX----
Crinetics Pharmaceuticals (CRNX)
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Crinetics Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jul 17, 2026Price forecast
$82.50-1.37%
Forecast & RatingHold
14analysts
- Strong buy14.29%
- Buy0.00%
- Hold85.71%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · 10 hours ago
13:41 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG
- Quartr · 2 days ago, 04:25 PM
CRNX: Pipeline advances in acromegaly, CAH, and NETs, with strong financial runway into 2030
- benzinga_article · 2 days ago, 02:52 PM
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why
- PR Newswire · 2 days ago, 01:51 PM
Are CRNX, VEEE, NXTC, TCBK Obtaining Fair Deals for their Shareholders?
- Global Report · 2 days ago, 04:13 AM
Market Insider: EV Charging Realities, Pharma Breakouts, and Under-the-Radar Movers
- Simplywall · Jul 20 at 08:14 PM
Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal Plans
